Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Quantum stocks stayed higher after Trump administrations denial of equity talks. Heres why (CNBC) +++ D-WAVE Aktie +3,23%

TRANSMEDICS Aktie

 >TRANSMEDICS Aktienkurs 
110.65 EUR    +7.4%    (Tradegate)
Ask: 111.1 EUR / 1000 Stück
Bid: 110.1 EUR / 1000 Stück
Tagesumsatz: 2222 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
TRANSMEDICS Aktie über LYNX handeln
>TRANSMEDICS Performance
1 Woche: +4,2%
1 Monat: -5,8%
3 Monate: +12,1%
6 Monate: +26,8%
1 Jahr: -10,6%
laufendes Jahr: +75,2%
>TRANSMEDICS Aktie
Name:  TRANSMEDICS GROUP
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US89377M1099 / A2PH5P
Symbol/ Ticker:  8T8 (Frankfurt) / TMDX (NASDAQ)
Kürzel:  FRA:8T8, ETR:8T8, 8T8:GR, NASDAQ:TMDX
Index:  -
Webseite:  https://www.transmedics.c..
Profil:  TransMedics Group Inc. is a medical technology com..
>Volltext..
Marktkapitalisierung:  3527.11 Mio. EUR
Unternehmenswert:  3627.42 Mio. EUR
Umsatz:  457.58 Mio. EUR
EBITDA:  86.39 Mio. EUR
Nettogewinn:  61.72 Mio. EUR
Gewinn je Aktie:  1.83 EUR
Schulden:  446.84 Mio. EUR
Liquide Mittel:  345 Mio. EUR
Operativer Cashflow:  99.28 Mio. EUR
Bargeldquote:  7.07
Umsatzwachstum:  34.66%
Gewinnwachstum:  2072.02%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  TRANSMEDICS
Letzte Datenerhebung:  23.10.25
>TRANSMEDICS Kennzahlen
Aktien/ Unternehmen:
Aktien: 34.09 Mio. St.
Frei handelbar: 96.64%
Rückkaufquote: -0.47%
Mitarbeiter: 728
Umsatz/Mitarb.: 0.52 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 20.76%
Bewertung:
KGV: 62.62
KGV lG: 51.21
KUV: 9.14
KBV: 12.96
PEG-Ratio: 0.01
EV/EBITDA: 41.99
Rentabilität:
Bruttomarge: 59.74%
Gewinnmarge: 13.49%
Operative Marge: 14.41%
Managementeffizenz:
Gesamtkaprendite: 8.69%
Eigenkaprendite: 28.21%
>TRANSMEDICS Peer Group

Es sind 597 Aktien bekannt.
 
23.10.25 - 17:27
TransMedics upgraded at Needham on strong US sales (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 17:30
TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
 
TransMedics (TMDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
15.10.25 - 22:09
TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025 (PR Newswire)
 
ANDOVER, Mass., Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial......
25.09.25 - 20:30
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network (Zacks)
 
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States....
24.09.25 - 17:30
Here′s Why TransMedics (TMDX) is a Strong Growth Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
22.09.25 - 08:06
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy (PR Newswire)
 
Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program ("NOP") hubs in Italy to support utilization of TransMedics' Organ Care System ("OCS") perfusion technology and increase donor organ utilization for patients in need TransMedics President and......
19.09.25 - 17:30
Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
09.09.25 - 07:15
Biotech Stocks Surge After Hours: CAPR, TMDX Lead Gains Amid Trial Updates And Earnings Momentum (RTTNews)
 
Several biotech and medical technology stocks posted notable gains in after-hours trading on Monday, with momentum driven by a mix of earnings optimism, clinical trial progress, and speculative positioning. While some names rallied on fresh developments-like TransMedics' FDA trial approval and Capricor's vaccine dosing milestone-others moved higher without specific news, suggesting technical......
04.09.25 - 20:33
TransMedics initiated with Hold at Stifel on mixed survey results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.08.25 - 19:45
Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
 
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program....
29.08.25 - 19:00
Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report? (Zacks)
 
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
25.08.25 - 22:06
TransMedics to Present at Upcoming September Investor Conferences (PR Newswire)
 
ANDOVER, Mass., Aug. 25, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in......
22.08.25 - 17:30
Here′s Why TransMedics (TMDX) is a Strong Momentum Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
20.08.25 - 17:30
Here′s Why TransMedics (TMDX) is a Strong Growth Stock (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
14.08.25 - 16:00
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics (Zacks)
 
Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching....
12.08.25 - 16:45
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average (Zacks)
 
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?...
11.08.25 - 18:24
TransMedics rises after CEO buys company stock (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.08.25 - 03:01
Insiderhandel: President & CEO kauft Aktien von TransMedics Group im Wert von 996912 USD (Insiderkauf)
 
Hassanein, Waleed H. - Vorstand - Tag der Transaktion: 2025-08-06...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Tormann muß Ruhe ausstrahlen, er muß nur aufpassen, daß er dabei nicht einschläft. - Sepp Maier
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!